G267-0199 Screening compound: N-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-oxo-6-[(pyridin-3-yl)methyl]-5,6-dihydro-1,6-naphthyridine-3-carboxamide

G267-0199 Screening compound: N-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-oxo-6-[(pyridin-3-yl)methyl]-5,6-dihydro-1,6-naphthyridine-3-carboxamide
G267-0199 Screening compound: N-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-oxo-6-[(pyridin-3-yl)methyl]-5,6-dihydro-1,6-naphthyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G267-0199
N-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-oxo-6-[(pyridin-3-yl)methyl]-5,6-dihydro-1,6-naphthyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G267-0199

Molecular Formula

C26H23N5O2 (C26 H23 N5 O2)

Compound Name

N-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-oxo-6-[(pyridin-3-yl)methyl]-5,6-dihydro-1,6-naphthyridine-3-carboxamide

IUPAC name

N-[2-(1H-indol-3-yl)ethyl]-2-methyl-5-oxo-6-[(pyridin-3-yl)methyl]-56-dihydro-16-naphthyridine-3-carboxamide

SMILES

Cc(c(C(NCCc1c[nH]c2c1cccc2)=O)c1)nc(C=CN2Cc3cnccc3)c1C2=O

InChI

InChI=1S/C26H23N5O2/c1-17-21(25(32)28-11-8-19-15-29-23-7-3-2-6-20(19)23)13-22-24(30-17)9-12-31(26(22)33)16-18-5-4-10-27-14-18/h2-7,9-10,12-15,29H,8,11,16H2,1H3,(H,28,32)

InChI Key

FRJKZBVKXDWATA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14991965

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.654

Distribution Coefficient, logD

2.654

Water Solubility, LogSw

-2.98

Polar Surface Area

70.018

Acid Dissociation Constant (pKa)

11.07

Base Dissociation Constant (pKb)

3.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.40

G267-0199 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with G267-0199 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G267-0199?
Check Price and Availability of G267-0199, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G267-0199 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G267-0199
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G267-0199
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G267-0199 available by request